Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Clasificar por
Keyphrases
Parkinson's Disease Model
100%
Overexpression
100%
Gdnf
100%
CRISPR Activation
100%
In Vitro Model
50%
Parkinson's Disease
33%
Genetic Material
33%
Astrocytes
16%
Reactive Oxygen Species
16%
Cell Differentiation
16%
Iron Oxide
16%
Cell Viability
16%
Neuroprotective Effect
16%
Microglia
16%
Cell Survival
16%
Medical Sciences
16%
Nanostructures
16%
Cell Growth
16%
Neuroinflammation
16%
Remediate
16%
Current Treatment
16%
Symptom Management
16%
Primary Culture
16%
Delivery System
16%
Endosomal Escape
16%
Targeted Delivery System
16%
Efficient Transport
16%
Basal Values
16%
Monoamine Oxidase B (MAO-B)
16%
Nanostructured Delivery Systems
16%
Major Challenges
16%
B Complex
16%
Innovative Approaches
16%
Effective Delivery
16%
Neurotoxin MPTP
16%
INIS
assessments
100%
nervous system diseases
100%
in vitro
100%
delivery
66%
genetics
33%
reduction
33%
symptoms
33%
nanostructures
33%
growth
16%
values
16%
increasing
16%
management
16%
proteins
16%
vehicles
16%
neurons
16%
diseases
16%
viability
16%
transport
16%
oxygen
16%
modulation
16%
side effects
16%
boron complexes
16%
magnetite
16%
Neuroscience
Parkinson's Disease
100%
In Vitro
100%
Genetics
33%
Reactive Oxygen Species
16%
Neuroprotective Agent
16%
Cell Viability
16%
Astrocyte
16%
Microglia
16%
Cell Survival
16%
Cell Growth
16%
Neurotoxin
16%
Mitochondrial Permeability Transition Pore
16%
Primary Culture
16%
Side Effect
16%